Devereaux, Philip J
$38,996,933.00 CAD
- Department
- Canadian Institutes of Health Research
- Program
- Research in Priority Areas
- Recipient country
- Canada
- Fiscal year
- 2022-2023
- Agreement period
- September 1, 2022 – August 31, 2025
- Reference
- cihr-irsc:236-2022-2023-Q3-00622
Published purpose
The specific objectives of this funding opportunity are to: • Establish a Pan-Canadian Clinical Trials Consortium that will enhance connections between domestic and international clinical trial networks to create efficiencies of scale and support high quality trials that are designed and sized to maximize their impact; • Increase the impact of clinical trials through improved research design, increased recruitment, and enhanced clinical trial network capacity in Canada, including through the development and seed funding of new clinical trial networks where there are currently gaps; • Build clinical trial capacity through training, mentorship, methods development, and information-sharing across member networks and other components of the CTF; • Maximize research impact and knowledge mobilization¿within and beyond the Consortium to help ensure evidence is integrated in and used to inform health policy, decision making and planning; and • Advance equitable access¿to clinical trials for Canadians regardless of geography, race/ethnicity, and socioeconomic status.
In plain English AI-generated
This funding supports the establishment of a Pan-Canadian Clinical Trials Consortium to improve clinical trial design, capacity, training, and equitable access across Canada, with the goal of informing health policy and decision-making.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.